Status:
COMPLETED
BCRL Prevention Pilot
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Obesity
Breast Cancer
Eligibility:
FEMALE
18-70 years
Brief Summary
The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 month...
Detailed Description
Breast cancer related lymphedema occurs in 20-30% of survivors. Weight loss could prevent onset. We seek to do a pilot study to establish feasibility of 1) recruiting survivors at risk for lymphedema ...
Eligibility Criteria
Inclusion
- Women
- Breast Cancer Survivors who had 5 or more lymph nodes removed and radiation to lymph nodes as part of treatment.
- Completed all treatments - no metastatic cancers
- Overweight or obese (BMI greater than or equal to 25 kg/m2)
- Medically and logistically able to participate in a weight loss and exercise program over 6 months.
- Diagnosed with breast cancer within the past 2 years.
Exclusion
- More than 2 years since breast cancer diagnosis
- Medical status that would preclude safety of participation in a weight loss and exercise program
- Metastatic cancer
- Already enrolled in a weight loss program
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01166672
Start Date
July 1 2010
End Date
October 1 2012
Last Update
October 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104